Established JCR Europe B.V. As New Subsidiary For Conducting Clinical Development Activities
29/09/2022 08:39
Sept 29 (Reuters) - JCR Pharmaceuticals Co Ltd 4552.T :
* ESTABLISHED JCR EUROPE B.V. AS NEW SUBSIDIARY FOR CONDUCTING CLINICAL
DEVELOPMENT ACTIVITIES
Source text for Eikon: ID:nTSuc836fd
Further company coverage: 4552.T
Recent news on JCR Pharmaceuticals
See all newsBrief: JCR Pharmaceuticals Receives Marketing Authorization In Kuwait For Izcargo
Italfarmaco And Jcr Pharmaceuticals Enter Into Exclusive License Agreement For Jr-141 In United States, Europe, And Latin America
Brief: Jcr Pharmaceuticals Receives Orphan Drug Designation For Givinostat In Japan
Brief: Medipal & JCR Dose First Patient In Global Phase I/II Trial OF JR-446 For Mucopolysaccharidosis Type IIIB
Table: Jcr Pharmaceuticals -Q1 group results